News

Published on 6 Mar 2024 on Investing.com

iTeos Therapeutics expands board with industry veteran By Investing.com


Article preview image

WATERTOWN, Mass. – iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical...

NASDAQ.ONCT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
10 Underperforming Stocks Insiders are Buying

In this article, we will take a detailed look at the 10 Underperforming Stocks Insiders are Buyin...

Insider Monkey via Yahoo Finance 11 Apr 2024

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Earnings Call Transcript March 7, 2024 Onctern...

Insider Monkey via Yahoo Finance 8 Mar 2024

iTeos Therapeutics expands board with industry veteran By Investing.com

WATERTOWN, Mass. – iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical...

Investing.com 6 Mar 2024

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In...

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving I...

Investing.com 27 Dec 2023

Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket By...

Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Investing.com 27 Dec 2023

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day...

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day...

Investing.com 26 Dec 2023

Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November - Adit Edtech...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on T...

Benzinga 26 Dec 2023

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Onct...

Insider Monkey via Yahoo Finance 11 Nov 2023

The Zacks Analyst Blog Highlights bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex...

For Immediate Release Chicago, IL – April 6, 2023 – Zacks.com announces the list of stocks featur...

Zacks via Yahoo Finance 6 Apr 2023

Oncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab Studies

Oncternal Therapeutics Inc (NASDAQ: ONCT) will suspend Phase 3 and the Phase 1/2 studies of zilov...

Benzinga via Yahoo Finance 4 Apr 2023